News & Perspective

Sep 03, 2019

Sep 03, 2019

News Scan for Sep 03, 2019

Baloxavir pediatric trial
Smallpox vaccine stockpile contract
Liberia Lassa emergency
H5N1 in Nepalese poultry

Jun 27, 2018

Jun 27, 2018

Flu Scan for Jun 27, 2018

FDA priority review for new flu drug
Southern Hemisphere flu rise
Avian flu outbreaks in poultry

Feb 24, 2015

Feb 24, 2015

Flu Scan for Feb 24, 2015

H7N9 infections in China
More H5N1 cases in Egypt
Global flu update

Feb 11, 2015

Feb 11, 2015

Flu Scan for Feb 11, 2015

Parotitis in flu patients
Global flu update
H7N9 in China
Avian flu in Taiwan, Bulgaria

Dec 29, 2014

Dec 29, 2014

Flu Scan for Dec 29, 2014

Flu keeps rising in US
H5N1 cases in Egypt
H7N9 cases in China region
Avian flu in 4 countries

Nov 11, 2008

Nov 11, 2008

US to give FAO $44 million for avian flu control

(CIDRAP News) – The United States will contribute another $44.4 million to the United Nations Food and Agriculture Organization's (FAO's) campaign to prevent and control avian influenza, the FAO announced today.

Aug 01, 2008

Aug 01, 2008

Trial of second-generation zanamivir shows promise

(CIDRAP News) – Two pharmaceutical companies that are developing a second-generation version of the inhaled antiviral drug zanamivir (Relenza) reported promising phase 2 results showing that one dose was as effective against influenza as a course of oseltamivir (Tamiflu).

Feb 01, 2008

Feb 01, 2008

Europe says Tamiflu-resistant virus seen in 9 countries

(CIDRAP News) – European officials yesterday reported more evidence that one of the three types of seasonal influenza viruses is showing resistance to oseltamivir (Tamiflu) and said this represents the first clear sign that the resistant variant can spread.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Pages

Sort Results By:

 Sort Results By:

Narrow results by:

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»